The effects of zwitterionic surfactants on skin barrier function

Understanding how surfactants affect skin barrier function is important for assessing their safety in consumer and industrial products. Prior research has shown that surfactants can alter the stratum corneum, the outermost skin layer, by interacting with its lipid structure. This can lead to increased permeability and potential toxicity. However, the specific impact of zwitterionic surfactants remains unclear. These compounds are used in various applications due to their mild properties, but their long-term effects on skin integrity are not well characterized. No prior work had resolved how different chain lengths or surfactant types influence permeability. This uncertainty drove the current investigation into five zwitterionic surfactants. The study aimed to clarify their effects on barrier function using in vitro models. The results could help guide safer surfactant use in occupational and environmental settings. This gap motivated the researchers to explore the mechanisms of surfactant-induced permeability.

The study aimed to evaluate how five zwitterionic surfactants affect the barrier function of hairless mouse skin. Specifically, the researchers wanted to determine the extent to which these surfactants enhance the permeation of a model compound. The goal was to identify the relationship between surfactant properties and their effects on skin permeability. The researchers also sought to investigate the mechanism behind the observed changes. They focused on the role of surfactant concentration and critical micelle concentration. The study aimed to provide insights into how surfactants interact with the stratum corneum. The findings could help assess the potential dermal toxicity of these compounds. This work is relevant for occupational and environmental exposure scenarios.

The researchers used excised hairless mouse skin in an in vitro model to assess surfactant effects. Five zwitterionic surfactants were tested at various concentrations. Each surfactant was applied to the skin for 16 hours. Nicotinamide was used as a model compound to measure permeation. The flux of nicotinamide through treated skin was compared to control samples. The surfactants tested included C12BET, C16BET, C16SUB, C12AO, and C12TAB. The study also used 14C-radiolabeled surfactants to track their absorption. Toxicity data from a different animal model were used for comparison.

All five surfactants reduced skin barrier function, but the extent varied. The degree of permeation enhancement was linked to the surfactant concentration relative to its critical micelle concentration. C12BET and C16BET showed different absorption profiles. C12BET was well absorbed into the receptor phase, while C16BET remained in the skin. Radiolabeling confirmed the differential partitioning of the two surfactants. The toxicity data suggested that C12BET had a lower dermal LD50 than C16BET. The findings support the hypothesis that lipid solubilization is a key mechanism. The results provide insights into surfactant-induced permeability changes.

The study suggests that zwitterionic surfactants can alter skin barrier function. The extent of permeation enhancement depends on surfactant concentration and micelle formation. The results support the idea that lipid solubilization plays a role in the observed effects. The differential absorption of C12BET and C16BET was consistent with toxicity data. The findings may help assess the potential dermal toxicity of these compounds. The study provides useful information for occupational and environmental exposure scenarios. The researchers propose that surfactant chain length influences both permeability and toxicity. These conclusions are based on the observed in vitro effects and available toxicity data.